1. Laevens H, Koenen F, Deluyker H, de Kruif A. Experimental infection of slaughter pigs with classical swine fever virus: transmission of the virus, course of the disease and antibody response. Vet Rec. 1999; 145:243–248.
Article
2. Fritzemeier J, Teuffert J, Greiser-Wilke I, Staubach C, Schlüter H, Moennig V. Epidemiology of classical swine fever in Germany in the 1990s. Vet Microbiol. 2000; 77:29–41.
Article
3. Moennig V, Floegel-Niesmann G, Greiser-Wilke I. Clinical signs and epidemiology of classical swine fever: a review of new knowledge. Vet J. 2003; 165:11–20.
Article
4. Rümenapf T, Unger G, Strauss JH, Thiel HJ. Processing of the envelope glycoproteins of pestiviruses. J Virol. 1993; 67:3288–3294.
Article
5. Meyers G, Thiel HJ. Molecular characterization of pestiviruses. Adv Virus Res. 1996; 47:53–118.
Article
6. Madera R, Gong W, Wang L, Burakova Y, Lleellish K, Galliher-Beckley A, et al. Pigs immunized with a novel E2 subunit vaccine are protected from subgenotype heterologous classical swine fever virus challenge. BMC Vet Res. 2016; 12:197.
Article
7. Huang YL, Deng MC, Wang FI, Huang CC, Chang CY. The challenges of classical swine fever control: modified live and E2 subunit vaccines. Virus Res. 2014; 179:1–11.
Article
8. Pauly T, Elbers K, König M, Lengsfeld T, Saalmüller A, Thiel HJ. Classical swine fever virus-specific cytotoxic T lymphocytes and identification of a T cell epitope. J Gen Virol. 1995; 76:3039–3049.
Article
9. Sasahara J, Kumagai T, Shimizu Y, Furuuchi S. Field experiments of hog cholera live vaccine prepared in guinea-pig kidney cell culture. Natl Inst Anim Health Q (Tokyo). 1969; 9:83–91.
10. Aynaud JM, Lejolly JC, Bibard C, Galicher C. [Studies of the properties of cold induced classical swine fever virus mutants. Application to vaccination]. Bull Off Int Epizoot. 1971; 75:654–659.
11. Je SH, Kwon T, Yoo SJ, Lee DU, Lee S, Richt JA, et al. Classical Swine Fever Outbreak after Modified Live LOM Strain Vaccination in Naive Pigs, South Korea. Emerg Infect Dis. 2018; 24:798–800.
Article
12. Hulst MM, Westra DF, Wensvoort G, Moormann RJ. Glycoprotein E1 of hog cholera virus expressed in insect cells protects swine from hog cholera. J Virol. 1993; 67:5435–5442.
Article
13. Moormann RJ, Bouma A, Kramps JA, Terpstra C, De Smit HJ. Development of a classical swine fever subunit marker vaccine and companion diagnostic test. Vet Microbiol. 2000; 73:209–219.
Article
14. van Rijn PA, Bossers A, Wensvoort G, Moormann RJ. Classical swine fever virus (CSFV) envelope glycoprotein E2 containing one structural antigenic unit protects pigs from lethal CSFV challenge. J Gen Virol. 1996; 77:2737–2745.
Article
15. Aboul-Ata AA, Vitti A, Nuzzaci M, El-Attar AK, Piazzolla G, Tortorella C, et al. Plant-based vaccines: novel and low-cost possible route for Mediterranean innovative vaccination strategies. Adv Virus Res. 2014; 89:1–37.
16. Lai H, Chen Q. Bioprocessing of plant-derived virus-like particles of Norwalk virus capsid protein under current Good Manufacture Practice regulations. Plant Cell Rep. 2012; 31:573–584.
Article
17. Guan ZJ, Guo B, Huo YL, Guan ZP, Dai JK, Wei YH. Recent advances and safety issues of transgenic plant-derived vaccines. Appl Microbiol Biotechnol. 2013; 97:2817–2840.
Article
18. Lau OS, Sun SSM. Plant seeds as bioreactors for recombinant protein production. Biotechnol Adv. 2009; 27:1015–1022.
Article
19. Kumar GB, Ganapathi TR, Bapat VA. Production of hepatitis B surface antigen in recombinant plant systems: an update. Biotechnol Prog. 2007; 23:532–539.
Article
20. Kumar GB, Srinivas L, Ganapathi TR, Bapat VA. Hepatitis B surface antigen expression in transgenic tobacco (Nicotiana tabacum) plants using four different expression cassettes. Plant Cell Tissue Organ Cult. 2006; 84:315–323.
Article
21. Conley AJ, Zhu H, Le LC, Jevnikar AM, Lee BH, Brandle JE, et al. Recombinant protein production in a variety of Nicotiana hosts: a comparative analysis. Plant Biotechnol J. 2011; 9:434–444.
Article
22. Park Y, An DJ, Choe S, Lee Y, Park M, Park S, et al. Development of Recombinant Protein-Based Vaccine Against Classical Swine Fever Virus in Pigs Using Transgenic Nicotiana benthamiana. Front Plant Sci. 2019; 10:624.
Article
23. Moennig V, Floegel-Niesmann G, Greiser-Wilke I. Clinical signs and epidemiology of classical swine fever: a review of new knowledge. Vet J. 2003; 165:11–20.
Article
24. Straw BE, Zimmerman JJ, D'Allaire S, Taylor DJ. Classical swine fever and other pestiviruses. Diseases of Swine. 9thed. Blackwell Publishing;2006. p. 309–322.
25. Dunne HW. Hog cholera (European swine fever). Adv Vet Sci Comp Med. 1973; 17:315–359.
26. Cha SH, Choi EJ, Park JH, Yoon SR, Kwon JH, Yoon KJ, et al. Phylogenetic characterization of classical swine fever viruses isolated in Korea between 1988 and 2003. Virus Res. 2007; 126:256–261.
Article
27. Yoon SS, Byun JW, Bae YC, Roh IS, Lee KH, Yeo DY, et al. Retrospective pathologic study on the classical swine fever outbreak in Korea. Korean Journal of Veterinary Public Health. 2010; 34:117–123.
28. Floegel-Niesmann G, Bunzenthal C, Fischer S, Moennig V. Virulence of recent and former classical swine fever virus isolates evaluated by their clinical and pathological signs. J Vet Med B Infect Dis Vet Public Health. 2003; 50:214–220.
Article
29. Kim JS, Shon SG, Lee JH. Hisopathological Study on the Field Cases of Hog Cholera. J Inst Develop of Livestock Prod. 1992; 19:15–31.
30. Patchimasiri T, Pinyochon W, Damrongwatanapokin S. Pathological study of chronic swine fever in experimental pigs. 24. Thai Veterinary Medical Association and 4. Bangkok(Thailand): Thailand Veterinary Practitioner Association Meeting;1998. 08. 5–7.
31. Narita M, Kawashima K, Kimura K, Mikami O, Shibahara T, Yamada S, et al. Comparative immunohistopathology in pigs infected with highly virulent or less virulent strains of hog cholera virus. Vet Pathol. 2000; 37:402–408.
Article